<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-id journal-id-type="hwp">bioinfo</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4184262</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btu419</article-id>
    <article-id pub-id-type="publisher-id">btu419</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>RAPIDR: an analysis package for non-invasive prenatal testing of aneuploidy</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Lo</surname>
          <given-names>Kitty K.</given-names>
        </name>
        <xref ref-type="aff" rid="btu419-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="corresp" rid="btu419-COR1">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Boustred</surname>
          <given-names>Christopher</given-names>
        </name>
        <xref ref-type="aff" rid="btu419-AFF1">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chitty</surname>
          <given-names>Lyn S.</given-names>
        </name>
        <xref ref-type="aff" rid="btu419-AFF1">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Plagnol</surname>
          <given-names>Vincent</given-names>
        </name>
        <xref ref-type="aff" rid="btu419-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <aff id="btu419-AFF1"><sup>1</sup>University College London Genetics Institute, University College London, UK and <sup>2</sup>North East Thames Regional Genetics Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK</aff>
    </contrib-group>
    <author-notes>
      <corresp id="btu419-COR1">*To whom correspondence should be addressed.</corresp>
      <fn id="FN1">
        <p>Associate Editor: Alfonso Valencia</p>
      </fn>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>15</day>
      <month>10</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>01</day>
      <month>7</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>01</day>
      <month>7</month>
      <year>2014</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>30</volume>
    <issue>20</issue>
    <fpage>2965</fpage>
    <lpage>2967</lpage>
    <history>
      <date date-type="received">
        <day>19</day>
        <month>3</month>
        <year>2014</year>
      </date>
      <date date-type="rev-recd">
        <day>5</day>
        <month>6</month>
        <year>2014</year>
      </date>
      <date date-type="accepted">
        <day>24</day>
        <month>6</month>
        <year>2014</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author 2014. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2014</copyright-year>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/" license-type="creative-commons">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Non-invasive prenatal testing (NIPT) of fetal aneuploidy using cell-free fetal DNA is becoming part of routine clinical practice. RAPIDR (Reliable Accurate Prenatal non-Invasive Diagnosis R package) is an easy-to-use open-source <italic>R</italic> package that implements several published NIPT analysis methods. The input to RAPIDR is a set of sequence alignment files in the BAM format, and the outputs are calls for aneuploidy, including trisomies 13, 18, 21 and monosomy X as well as fetal sex. RAPIDR has been extensively tested with a large sample set as part of the RAPID project in the UK. The package contains quality control steps to make it robust for use in the clinical setting.</p>
      <p><bold>Availability and implementation:</bold> RAPIDR is implemented in <italic>R</italic> and can be freely downloaded via CRAN from here: <ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org/web/packages/RAPIDR/index.html">http://cran.r-project.org/web/packages/RAPIDR/index.html</ext-link>.</p>
      <p>
        <bold>Contact:</bold>
        <email>kitty.lo@ucl.ac.uk</email>
      </p>
      <p><bold>Supplementary information:</bold><ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btu419/-/DC1">Supplementary data</ext-link> are available at <italic>Bioinformatics</italic> online.</p>
    </abstract>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 INTRODUCTION</title>
    <p>Since the first demonstration of the use of cell-free DNA (cfDNA) to detect aneuploidy (<xref rid="btu419-B1" ref-type="bibr">Chiu <italic>et al.</italic>, 2008</xref>; <xref rid="btu419-B3" ref-type="bibr">Fan <italic>et al.</italic>, 2008</xref>), many groups around the world have reported large studies showing high sensitivities and specificities for the detection of trisomies 13, 18 and 21 (<xref rid="btu419-B4" ref-type="bibr">Jiang <italic>et al.</italic>, 2012</xref>; <xref rid="btu419-B6" ref-type="bibr">Palomaki <italic>et al.</italic>, 2011</xref>; <xref rid="btu419-B8" ref-type="bibr">Sehnert <italic>et al.</italic>, 2011</xref>). In contrast to invasive methods such as amniocentesis, non-invasive prenatal testing (NIPT) uses cfDNA in maternal plasma and does not present a risk of miscarriage. Currently, outside the context of research studies, NIPT for aneuploidy is only available from commercial providers.</p>
    <p>To perform NIPT, cfDNA is extracted from maternal plasma and sequenced using short reads and high-throughput DNA sequencing. Sequenced reads are aligned to the reference human genome using a short read aligner. Aneuploidy is called if the number of reads mapped to each chromosome differs from its expectation based on a comparison with a set of baseline samples. The general approach is usually referred to as a read depth strategy.</p>
    <p>A number of factors influence test performance, for example the fetal fraction (i.e. the proportion of reads originating from the fetus), and other technical parameters such as read length and coverage (<xref rid="btu419-B2" ref-type="bibr">Fan and Quake, 2010</xref>). The choice of sequencing parameters needs to be balanced against costs. Previous studies have shown that an acceptable level of test sensitivity can be reached with relatively short read lengths (36–52 bp) and modest coverage (2–10 million reads per sample) (<xref rid="btu419-B5" ref-type="bibr">Liang <italic>et al.</italic>, 2013</xref>; <xref rid="btu419-B8" ref-type="bibr">Sehnert <italic>et al.</italic>, 2011</xref>).</p>
    <p>Here, we present a flexible and robust <italic>R</italic> package for NIPT analysis called RAPIDR (Reliable Accurate Prenatal non-Invasive Diagnosis R package). RAPIDR combines several analytical techniques that have been proposed for NIPT analysis and has been tested with a large sample set from the RAPID project (NIHR funded project to evaluate the use of NIPT). RAPID validation results can be found in the <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btu419/-/DC1">Supplementary Material</ext-link> (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btu419/-/DC1">Supplementary Figs S1–S4</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btu419/-/DC1">Supplementary Text S1</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btu419/-/DC1">Supplementary Tables S1</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btu419/-/DC1">S2</ext-link>).</p>
  </sec>
  <sec id="SEC2">
    <title>2 CORRECTION FOR TECHNICAL ARTEFACTS</title>
    <p>The NIPT workflow is illustrated in <xref ref-type="fig" rid="btu419-F1">Figure 1</xref>a. RAPIDR handles the processing steps after reads have been sequenced and aligned, i.e. it starts from the BAM files. It uses the Rsamtools and the GenomicRanges R packages to parse the BAM files and count the number of reads in predefined bins (20 kb as default bin length, which must be sufficiently large to obtain at least 20 reads per bin).
<fig id="btu419-F1" position="float"><label>Fig. 1.</label><caption><p>(<bold>a</bold>) Workflow of NIPT; (<bold>b</bold>) The <italic>z</italic>-scores across all the autosomes for a T21 sample, the triangles highlight chromosomes 13, 18 and 21 for which we test for aneuploidy; (<bold>c</bold>) Visual display of the criteria used to call fetal sex and chromosome aneuploidy</p></caption><graphic xlink:href="btu419f1p"/></fig></p>
    <p>Raw read counts from high-throughput sequencing technologies typically do not follow theoretical counting statistics. The excess variance, introduced in part by the polymerase chain reaction steps, is correlated with the GC content of the DNA sequence. Various methods have been proposed to correct for these biases. RAPIDR implements two methods from the literature: the normalized chromosome value (NCV) method (<xref rid="btu419-B8" ref-type="bibr">Sehnert <italic>et al.</italic>, 2011</xref>) and weighting of counts by GC content bin (<xref rid="btu419-B2" ref-type="bibr">Fan and Quake, 2010</xref>). These methods require a reference sample set, in contrast to the open source tool described by <xref rid="btu419-B9" ref-type="bibr">Straver <italic>et al.</italic> (2014)</xref>. NCV computes the ratio between the counts mapped to the chromosome of interest and another chromosome. The chromosome used in the denominator is chosen to minimize the variance of the NCV ratios. In the GC bin weighting method (<xref rid="btu419-B2" ref-type="bibr">Fan and Quake, 2010</xref>), we first determine the read count in each bin, and then compute the average count as a function of GC content (using discrete intervals of 0.5% for GC proportion). Counts in each bin are then weighted by <inline-formula><mml:math id="I1"><mml:mrow><mml:msub><mml:mi>W</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mover accent="true"><mml:mi>M</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>/</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, where <inline-formula><mml:math id="I2"><mml:mover accent="true"><mml:mi>M</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></inline-formula> is the average counts across all bins and <italic>M<sub>i</sub></italic> is the average count in bin <italic>i</italic>. We also implemented a third method for GC correction based on principal component analysis (PCA), which as far we know, has not been used in the context of NIPT. In the PCA method, we first use the euploid samples in the baseline set to find the principal components by treating the count ratios in each bin as a variable. Then, we regress the count ratios in each bin with the first 10 principal components, with the assumption that they represent systematic noise. We find that PCA provides higher sensitivity than GC bin weighting correction in exchange for lower specificity (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btu419/-/DC1">Supplementary Table S1</ext-link>).</p>
    <p>Low complexity and repetitive regions are common in the human genome, which complicates the alignment of short sequencing reads. We recommend only keeping uniquely mapped reads. RAPIDR provides the option to mask out parts of genome known to be of low complexity. By default, it excludes bins with abnormally high read counts from the analysis.</p>
  </sec>
  <sec id="SEC3">
    <title>3 CALLING OF ANEUPLOIDY AND FETAL SEX</title>
    <p>Once artifacts have been removed from the read counts, the next step is for RAPIDR to create a baseline using a set of reference samples with known outcomes and fetal sex. For each sample, RAPIDR calculates the ratio of reads mapped to each chromosome compared with the reads mapped to all the autosomes (call this ratio <italic>r<sub>ij</sub></italic> for chromosome <italic>i</italic> and sample <italic>j</italic>). Using the set of reference samples without known aneuploidy, it then computes the mean (<inline-formula><mml:math id="I3"><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) and SD (<inline-formula><mml:math id="I4"><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) of <italic>r<sub>ij</sub></italic> for chromosomes 21, 18 and 13. To call chromosomal abnormalities, it calculates a z-score <italic>z<sub>ij</sub></italic> for each sample–chromosome pair (<xref ref-type="fig" rid="btu419-F1">Fig. 1</xref>b). A trisomy is called if that <italic>z</italic>-score exceeds a specified threshold (typically <italic>z</italic> &gt; 3). We estimate that a relatively small reference sample set is sufficient to provide accurate results, however a bigger reference sample set would ensure any inter-run variabilities are captured. (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btu419/-/DC1">Supplementary Text S2</ext-link>).</p>
    <p>An important issue is technical sample-to-sample variability. If a sample is technically too distinct, it will not be appropriate to include it in the baseline. We propose quality control checks to ensure that such technical issues are not affecting the calls. One useful check is to make sure that the z-score for all autosomes (aside from the chromosomes for which we suspect aneuploidy) fall between the expected range. RAPIDR provides functions to report and visualize this easily, and <xref ref-type="fig" rid="btu419-F1">Figure 1</xref>b shows the quality control output from one sample.</p>
    <p>A different and slightly more complex process is required to determine fetal sex and to call monosomy X abnormalities. Given an unknown sample, the <italic>z</italic>-score is calculated for chr X and chr Y (<italic>z<sub>X</sub></italic> and <italic>z<sub>Y</sub></italic>), with the following rules being applied sequentially—if <italic>z<sub>Y</sub></italic> &gt; 3, the sample is called male; if <inline-formula><mml:math id="I5"><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mi>X</mml:mi></mml:msub><mml:mo>&gt;</mml:mo><mml:mo>−</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></inline-formula>, the sample is called female; if <inline-formula><mml:math id="I6"><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mi>X</mml:mi></mml:msub><mml:mo>&lt;</mml:mo><mml:mo>−</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></inline-formula>, the sample is called as monosomy X; finally, if <italic>z<sub>X</sub></italic> is between −2 and −3, then the sample sex is called as unknown (<xref ref-type="fig" rid="btu419-F1">Fig. 1</xref>c). To improve the accuracy of fetal sex calling, we also excluded bins in chr Y with a high number of counts mapped from females, e.g. the pseudo-autosomal region of chr Y.</p>
    <p>For euploid males, RAPIDR also estimates the fetal fraction using the method from <xref rid="btu419-B7" ref-type="bibr">Rava <italic>et al.</italic> (2014)</xref>. Fetal fraction is an important determinant of NIPT sensitivity, but it cannot be measured directly using the protocol we described.</p>
  </sec>
  <sec>
    <title>4 CONCLUSION</title>
    <p>In this article, we described the RAPIDR package for NIPT of fetal aneuploidies. RAPIDR has been validated using &gt;700 samples and delivers an acceptable level of specificity and sensitivity for T21, T18, T13 and monosomy X. The system requirement for RAPIDR is modest (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btu419/-/DC1">Supplementary Text S3</ext-link>). Future work on RAPIDR will include evaluating strategies to detect sub-chromosomal abnormalities.</p>
    <p><italic>Funding</italic>: This manuscript presents independent research funded by the <funding-source>National Institute for Health Research (NIHR)</funding-source> under the Program Grants for Applied Research Program (<award-id>RP-PG-0707-10107</award-id>) (the RAPID project) and the <funding-source>NIHR Biomedical Research Centre at Great Ormond Street Hospital</funding-source>. L.S.C. is partially funded by the <funding-source>Great Ormond Street Hospital Children’s Charity</funding-source>. The views expressed are those of the authors and not necessarily those of the <funding-source>NHS</funding-source>, the <funding-source>NIHR</funding-source> or the <funding-source>Department of Health</funding-source>.</p>
    <p><italic>Conflict of interest</italic>: none declared.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="PMC_1" content-type="local-data">
      <caption>
        <title>Supplementary Data</title>
      </caption>
      <media mimetype="text" mime-subtype="html" xlink:href="supp_30_20_2965__index.html"/>
      <media xlink:role="associated-file" mimetype="application" mime-subtype="msword" xlink:href="supp_btu419_supp_materials.docx"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="btu419-B1">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chiu</surname>
            <given-names>RW</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2008</year>
        <volume>105</volume>
        <fpage>20458</fpage>
        <lpage>20463</lpage>
        <pub-id pub-id-type="pmid">19073917</pub-id>
      </element-citation>
    </ref>
    <ref id="btu419-B2">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fan</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Quake</surname>
            <given-names>SR</given-names>
          </name>
        </person-group>
        <article-title>Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics</article-title>
        <source>PLoS One</source>
        <year>2010</year>
        <volume>5</volume>
        <fpage>e10439</fpage>
        <pub-id pub-id-type="pmid">20454671</pub-id>
      </element-citation>
    </ref>
    <ref id="btu419-B3">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fan</surname>
            <given-names>HC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2008</year>
        <volume>105</volume>
        <fpage>16266</fpage>
        <lpage>16271</lpage>
        <pub-id pub-id-type="pmid">18838674</pub-id>
      </element-citation>
    </ref>
    <ref id="btu419-B4">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Noninvasive fetal trisomy (nifty) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies</article-title>
        <source>BMC Med. Genomics</source>
        <year>2012</year>
        <volume>5</volume>
        <fpage>57</fpage>
        <pub-id pub-id-type="pmid">23198897</pub-id>
      </element-citation>
    </ref>
    <ref id="btu419-B5">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liang</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing</article-title>
        <source>Prenat. Diagn.</source>
        <year>2013</year>
        <volume>33</volume>
        <fpage>409</fpage>
        <lpage>415</lpage>
        <pub-id pub-id-type="pmid">23299662</pub-id>
      </element-citation>
    </ref>
    <ref id="btu419-B6">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Palomaki</surname>
            <given-names>GE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study</article-title>
        <source>Genet. Med.</source>
        <year>2011</year>
        <volume>13</volume>
        <fpage>913</fpage>
        <lpage>920</lpage>
        <pub-id pub-id-type="pmid">22005709</pub-id>
      </element-citation>
    </ref>
    <ref id="btu419-B7">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rava</surname>
            <given-names>RP</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X</article-title>
        <source>Clin. Chem.</source>
        <year>2014</year>
        <volume>60</volume>
        <fpage>243</fpage>
        <lpage>250</lpage>
        <pub-id pub-id-type="pmid">24046201</pub-id>
      </element-citation>
    </ref>
    <ref id="btu419-B8">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sehnert</surname>
            <given-names>AJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood</article-title>
        <source>Clin. Chem.</source>
        <year>2011</year>
        <volume>57</volume>
        <fpage>1042</fpage>
        <lpage>1049</lpage>
        <pub-id pub-id-type="pmid">21519036</pub-id>
      </element-citation>
    </ref>
    <ref id="btu419-B9">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Straver</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Wisecondor: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2014</year>
        <volume>42</volume>
        <fpage>e31</fpage>
        <pub-id pub-id-type="pmid">24170809</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
